LATEST PRESS RELEASES

AMP German Cannabis Group Presents Roundtable Discussion with European Medical Cannabis Expert, Dr. Franjo Grotenhermen and Dr. Stefan Feuerstein about Medical Cannabis in Germany

AMP German Cannabis Group Presents Roundtable Discussion with European Medical Cannabis Expert, Dr. Franjo Grotenhermen and Dr. Stefan Feuerstein about Medical Cannabis in Germany

ERFURT and BERLIN, Germany, Aug. 4, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) proudly presents its first video in a series of in-depth roundtable discussions that will explore and discuss new developments regarding medical cannabis in Germany. The Roundtable Series online videos are in German... Read More...
Australis Capital Announces the Termination by Passport Technology of Pending Acquisition Agreement

Australis Capital Announces the Termination by Passport Technology of Pending Acquisition Agreement

LAS VEGAS, Aug. 3, 2020 - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA") announces that it has been informed by Passport Technology, Inc. ("Passport") that Passport has terminated the pending acquisition agreement previously announced by AUSA on June 25, 2020. The terms of the acquisition agreement require Passport to pay a brea... Read More...
Emerald Health Therapeutics Announces Stock Option Grant

Emerald Health Therapeutics Announces Stock Option Grant

Vancouver, British Columbia--(Newsfile Corp. - August 3, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") announces that it has issued an aggregate of 3,800,000 stock options to employees, consultants and directors at an exercise price of $0.21 per common share for a period of five years. All stock options ... Read More...
Terra Tech Corp. Schedules Second Quarter 2020 Earnings Release for Friday, August 7, 2020

Terra Tech Corp. Schedules Second Quarter 2020 Earnings Release for Friday, August 7, 2020

IRVINE, CA / ACCESSWIRE / August 3, 2020 / Terra Tech Corp. (OTCQX:TRTC) ("Terra Tech") or (the "Company") today announced that it will release its Second Quarter 2020 results on Friday, August 7, 2020 after U.S. markets close.The company will also host a conference call on Friday, August 7, 2020 at 4:30 PM Eastern Time.Dial-In Number: 1-... Read More...
Cara Therapeutics to Announce Second Quarter 2020 Financial Results on August 10, 2020

Cara Therapeutics to Announce Second Quarter 2020 Financial Results on August 10, 2020

STAMFORD, Conn., Aug. 03, 2020 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs, today announced that the Company will host a conference call and live audio... Read More...
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences

Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences

Norwood, MA, Aug. 03, 2020 -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present at two upcoming confe... Read More...
FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex

FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex

– Age-range for all EPIDIOLEX indications expanded to include patients one year of age and older –– Third indication approved for EPIDIOLEX, the only FDA-approved Cannabidiol (CBD) medicine –                    CARLSBAD, Calif., Aug. 03, 2020 -- GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and comme... Read More...
IAnthus Reports Fiscal 2019 Financial Results and Provides Additional Business Updates

IAnthus Reports Fiscal 2019 Financial Results and Provides Additional Business Updates

NEW YORK and TORONTO, July 31, 2020 - iAnthus Capital Holdings, Inc. ("iAnthus") (CSE: IAN) (OTCQX: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, reports its financial results for the year ended December 31, 2019. The Company's Financial Statements for the year ended December 31, 2... Read More...
FSD Pharma Inc., Developing its PEA Compound to Treat COVID-19, CEO Clip Video

FSD Pharma Inc., Developing its PEA Compound to Treat COVID-19, CEO Clip Video

Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) CEO and Chairman, Raza Bokhari speaks about the company's lead Compound, PEA, to treat COVID-19.If you cannot view the video above, please visit:https://www.b-tv.com/fsd-pharma-compound-to-treat-covid-19-ceo-clip-90sec/FSD Pharma wil... Read More...
Hill Street Amends Warrant Terms

Hill Street Amends Warrant Terms

Toronto, Ontario--(Newsfile Corp. - July 31, 2020) - Hill Street Beverage Company Inc. (TSXV: BEER) ("Hill Street" or the "Company"), announces that further to its press release dated July 21, 2020, the Company has received TSX Venture Exchange approval to extend the expiry date of 19,405,804 warrants of the Company that were set to expir... Read More...
UPDATE - Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

UPDATE – Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, July 31, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV) (OTCQB: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the U.S. Food & Drug Administration (“U.S. FDA”) has approved the Company ... Read More...
Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, July 31, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the U.S. Food & Drug Administration (“U.S. FDA”) has approved the Company to proceed with... Read More...
Cannabis One Holdings Inc. Announces Strategic Rebranding to INDVR Brands Inc. and Officer and Director Updates

Cannabis One Holdings Inc. Announces Strategic Rebranding to INDVR Brands Inc. and Officer and Director Updates

Vancouver, British Columbia and Denver, Colorado--(Newsfile Corp. - July 31, 2020) - Cannabis One Holdings Inc. (CSE: CBIS) ("Cannabis One", "CBIS", or the "Company") is pleased to announce that it has commenced the process of changing its name to "INDVR Brands Inc.", as well as changing its ticker symbol to "IDVR". The name change does n... Read More...
TerrAscend Opens Its' Newest Apothecarium Dispensary in Berkeley, California

TerrAscend Opens Its’ Newest Apothecarium Dispensary in Berkeley, California

Fourth Apothecarium Open in California and Seventh Nationwide NEW YORK and TORONTO, July 31, 2020 - TerrAscend Corp. (CSE:TER) (OTCQX: TRSSF) ("TerrAscend") today announced that it has officially opened its seventh retail dispensary location. The new 4,200 square foot Apothecarium dispensary, located at 2312 Telegraph Ave, Berkeley, CA ("... Read More...
Alcanna Inc. Announces Timing of Second Quarter 2020 Earnings Release

Alcanna Inc. Announces Timing of Second Quarter 2020 Earnings Release

EDMONTON, Alberta, July 31, 2020 -- Alcanna Inc. (the “Company” or “Alcanna”) (TSX: CLIQ) today announced that it plans to release its second quarter 2020 financial results after markets close on August 19, 2020.  Management will conduct a conference call on August 20, 2020 at 12:00p.m. ET (10:00a.m. MT) to discuss its second quarter oper... Read More...
Emerald Health Therapeutics and Quinto Resources Enter into Share Purchase Agreement for Sale of Quebec Cannabis Business

Emerald Health Therapeutics and Quinto Resources Enter into Share Purchase Agreement for Sale of Quebec Cannabis Business

Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) ("Emerald") and Quinto Resources Inc. ("Quinto") (TSXV: QIT) today announced that they have entered into a share purchase agreement dated July 30, 2020 (the "Agreement") in respect of the sale of Emerald's wholly-owned subsidiarie... Read More...
Canopy Growth to Report First Quarter Fiscal 2021 Financial Results on August 10, 2020

Canopy Growth to Report First Quarter Fiscal 2021 Financial Results on August 10, 2020

SMITHS FALLS, ON, July 31, 2020 - Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NYSE: CGC) will release its financial results for the first quarter fiscal 2021 ended June 30, 2020 before financial markets open on August 10, 2020. Following the release of its first quarter fiscal 2021 financial results, Canopy Growth will host a... Read More...
Cresco Labs to Report Second Quarter 2020 Financial Results on August 20th, 2020

Cresco Labs to Report Second Quarter 2020 Financial Results on August 20th, 2020

CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report its financial results for the second quarter ended June 30th, 2020 on Thursday, August 20th, 2020 after market close. T... Read More...
CGOC Acquires Multiple Voting Shares of a Current Investee Company

CGOC Acquires Multiple Voting Shares of a Current Investee Company

TORONTO, July 31, 2020 - Cannabis Growth Opportunity Corporation ("CGOC", or the "Company") (CSE: CGOC), a cannabis focused investment corporation with both public and private cannabis holdings, announced today that on July 30, 2020, the Company privately purchased and acquired 10,000 multiple voting shares ("Multiple Voting Shares") of B... Read More...
Leviathan Natural Products Increases Value of Debt Facility

Leviathan Natural Products Increases Value of Debt Facility

Toronto, Ontario--(Newsfile Corp. - July 30, 2020) - Leviathan Natural Products Inc. (CSE: EPIC) (the "Company" or "Leviathan") announces that effective July 24, 2020, it increased the value of a debt facility with a major shareholder from $5.0 million to $5.5 million at the same terms and conditions as the original agreement.The terms of... Read More...
Liberty Health Sciences Reports Fiscal Year 2021 First Quarter Financial Results

Liberty Health Sciences Reports Fiscal Year 2021 First Quarter Financial Results

*Note: All references to dollar values refer to Canadian dollars unless otherwise stated. TORONTO, July 30, 2020 - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty"), a provider of high-quality cannabis, announced its financial results for the first quarter ended May 31, 2020. Consolidated net... Read More...
CO2 GRO Inc. Announces Its First Commercial Feasibility in California with Strong Agronomy Management, Inc.

CO2 GRO Inc. Announces Its First Commercial Feasibility in California with Strong Agronomy Management, Inc.

TORONTO, ON / ACCESSWIRE / July 30, 2020 / Toronto based CO2 GRO Inc. ("GROW") (TSXV:GROW) (OTCQB:BLONF) (Frankfurt:4021) is pleased to announce that it will install a Commercial Feasibility CO2 Delivery Solutions™' VCO2 system at Strong Agronomy Management Inc.'s ("Strong Agronomy") Coastal Star Cannabis Nursery greenhouses in Californi... Read More...
Nextleaf Solutions Announces Completion of Acquisition of Licensed Processor

Nextleaf Solutions Announces Completion of Acquisition of Licensed Processor

Vancouver, British Columbia--(Newsfile Corp. - July 30, 2020) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) ("Nextleaf", "OILS", or the "Company"), Canada's most innovative cannabis extractor, is pleased to announce that it has completed the previously announced acquisition of all of the issued and outstanding shares of Nextleaf La... Read More...
MariMed Nature's Heritage Flower Brand Expands Product Offerings to Meet Strong Consumer Demand

MariMed Nature’s Heritage Flower Brand Expands Product Offerings to Meet Strong Consumer Demand

Launched February 2020, Nature’s Heritage has quickly become a top selling flower brand in MassachusettsCapitalizing on high consumer demand, Nature’s Heritage will expand its product offerings to include concentrates, vaporizers, and pre-rolls in Q3 2020 NORWOOD, Mass., July 30, 2020 -- MariMed Inc. (MRMD:OTCQX) (the “Company” or “MariMe... Read More...
Ventura Cannabis (VCAN) Posts First Quarter Financial Statements; Highlights Cannabis Holdings

Ventura Cannabis (VCAN) Posts First Quarter Financial Statements; Highlights Cannabis Holdings

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED.LOS ANGELES, July 30, 2020 -- Ventura Cannabis and Wellness Corp. (CSE:VCAN) (“Ventura Cannabis”, “Ventura”, “VCAN” or the “Company”) posted its financial statements and accompanying... Read More...
4Front Ventures to Reopen its Mission Dispensary in Chicago; Receives Approval for Retail Expansion in Calumet City, IL

4Front Ventures to Reopen its Mission Dispensary in Chicago; Receives Approval for Retail Expansion in Calumet City, IL

Company receives special use permit for additional Illinois retail locationMission South Chicago will reopen with a rededication rally on Friday, July 31 at 9AM CTPHOENIX, July 30, 2020 -- 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front") continues to focus its efforts in the Illinois market and is pleased to announce that its M... Read More...
Corbus Pharmaceuticals to Report Second Quarter Results on August 6, 2020 

Corbus Pharmaceuticals to Report Second Quarter Results on August 6, 2020 

Management to host conference call and webcast on Thursday, August 6 at 8:30 a.m. ETNorwood, MA, July 30, 2020 -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that it wi... Read More...
Neptune to Report Fiscal 2021 First Quarter Financial Results on August 11, 2020

Neptune to Report Fiscal 2021 First Quarter Financial Results on August 11, 2020

LAVAL, QC, July 30, 2020 - Neptune Wellness Solutions Inc. ("Neptune") (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health and wellness company focused on natural, plant-based, sustainable and purpose-driven lifestyle brands, announced today that it will report its financial results for the fiscal 2021 first quarter afte... Read More...
Sundial Growers to Announce Second Quarter 2020 Financial Results on August 13, 2020

Sundial Growers to Announce Second Quarter 2020 Financial Results on August 13, 2020

CALGARY, AB, July 30, 2020 - Sundial Growers (Nasdaq: SNDL) ("Sundial") announced today that it will release its second quarter financial results ended June 30, 2020 after market close on August 13, 2020. Following the release of its second quarter financial results, Sundial will host a conference call and webcast at 10:30 a.m. EDT (8:30... Read More...
Cresco Labs Announces Appointment of Carol Vallone to its Board and the Retirement of Brian McCormack

Cresco Labs Announces Appointment of Carol Vallone to its Board and the Retirement of Brian McCormack

Cresco Labs (CSE:CL) (OTCQX:CRLBF) ("Cresco" or "the Company"), one of the largest vertically integrated multistate cannabis operators in the United States, today announced additional actions in board refreshment and corporate governance to further strengthen its leadership in the cannabis industry.This press release features multimedia. ... Read More...
Aleafia Health Launches Same-Day, Direct-to-Door Medical Cannabis Delivery

Aleafia Health Launches Same-Day, Direct-to-Door Medical Cannabis Delivery

TORONTO, July 30, 2020 -- Aleafia Health Inc.’s (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) AssureHome Delivery, the industry-leading direct-to-door medical cannabis service, has now launched same-day delivery. Previously, the service offered next-day delivery only. Highlights include:Medical cannabis orders received before ... Read More...
PreveCeutical Announces Appointment of Director and Public Officer

PreveCeutical Announces Appointment of Director and Public Officer

Vancouver, British Columbia--(Newsfile Corp. - July 30, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce the appointment of Edward James Henderson as the Public Officer and Director of its subsidiary company, PreveCeutical (Australia) Pty Ltd. (the "Subsid... Read More...
Yield Growth Closes $1.4 Million Financing

Yield Growth Closes $1.4 Million Financing

Vancouver, British Columbia--(Newsfile Corp. - July 30, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) (the "Company") announces that it has closed financings totalling $1.4 million this week. The financing consisted of $700,000 in units offered through a shelf prospectus supplement at a price of $0.10 per unit (each... Read More...
IONIC BRANDS CORP Provides Update to Shareholders on Its Financial Filings

IONIC BRANDS CORP Provides Update to Shareholders on Its Financial Filings

IONIC BRANDS Audit update and Subsequent Quarterly filings TACOMA, WA / ACCESSWIRE / July 30, 2020 / IONIC BRANDS CORP. (CSE:IONC)(OTC PINK:IONKF)(FRA:1B3) ("IONIC BRANDS" or the "Company") is pleased to provide an update to shareholders regarding its current financial filing status for the year ended December 31, 2019 audit, and correspo... Read More...